page

Training SiteTraining Site
About Us | Contact Us | Test Link
Home > News Listing > CBD Unlimited Engages Private Sales Group Under the Subsidiary Name CBD Health Solutions

CBD Unlimited Engages Private Sales Group Under the Subsidiary Name CBD Health Solutions

5-52-2019 8:3 Endexx Corporation

Cave Creek, AZ - (NewMediaWire) - March 5, 2019 - CBD Unlimited, Inc. (OTC: EDXC) formerly known as Endexx Corporation (EDXC), a provider of innovative phytonutrient-based food and nutritional products, is pleased to announce its subsidiary, CBD Health Solutions, has engaged a private sales group to expand CBD Unlimited’s product reach, both nationally and internationally. CBD Health Solutions, LLC. was acquired by CBD Unlimited in 2015.

“As we grow CBD Unlimited’s salesforce, we will have the capacity to enter several markets across the U.S. and internationally,” commented CEO & Chairman Todd Davis. “While scaling business exponentially, it remains evident to appoint a dedicated team with the consumer in mind. We plan to reach each and every consumer possible, who will truly benefit from our products.” 

This independently operated sales team will initially launch with a 25-person salesforce, expanding up to a 500-person salesforce over the next 2 years. The salesforce will help drive CBD Unlimited’s continued nationwide growth and expansion. 

About CBD Unlimited, Inc.

CBD Unlimited, Inc., with its collaborative partners and consultants, develops and distributes two consumable product lines derived from Hemp, which is all-natural and rich in phyto-cannabinoids. Phyto-Bites® is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation.

The company also has two key technology products and services that launched in 2014. Both products provide essential solutions to promote regulatory compliance and full accountability through asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is the first standardized hardware agnostic and software solution for tracking high- risk high-shrink regulated and restricted products that maintains compliance with federal, state and local regulations. It is intended to provide conformity with federal and state mandates. Gorilla-Tek™ is also a commercial-grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Gorilla-Tek™ increases productivity and reduces costs for retailers, while enhancing their service quality by reducing transaction time for customers.

Websites include: www.cbdunlimited.com, and www.phytobites.com.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Contact:

For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
Todd@cbdunlimited.com
480-595-6900



hello4
  • Home
  • AD-2972 Test - 7/21
  • Post-deployment Test Pages
  • Pre Deployment Test Pages
  • Pre-deployment Test Nav | 1 MAR 2026
  • Pre-deployment Test Nav | 17 FEB 2026
  • Scheduled Deployment - 12 February 2026 | Test Nav
  • Pre-deployment Test Page - 24 OCT 2025
  • new registr
  • This is a test Page
  • This is another test page
  • Social Media
  • Media Page
  • Test for Content Builder
  • Test Custom Form Page
  • Test Fields
  • Custom Form 2
  • All news are here
  • Author List
  • Social Hub
  • Photo Submission
  • External Endroser
  • Endorser
  • Social Media
  • Visual Library
  • File Upload
  • Request Community
  • testtoday
  • My Profile
  • My Requests
  • Test 060
  • TEST CT
  • My Basic Page
  • Category Filter test
  • Custom Content Type Test
  • Backgrounder
  • Biographies
  • Blog
  • Search
  • Fact Sheets
  • Events
  • In the News
  • News Listing
    • Multimedia
    • Test Index
  • Photo
  • Audio
  • Video
  • Documents
test content to check template
Calley Hollon
Client Services
iPR Software
310-499-0544
devsaduser1264@ipressroom.com
Gino Reyes
devsaduser2849@ipressroom.com
Yo Yo
devsaduser246@ipressroom.com
Jibin John
devsaduser2089@ipressroom.com

Recent Releases

July 16, 2026

CMS-538 TC-051 Test Page

/ / Save Image
April 02, 2026

Just a test

just a test
March 27, 2026

Just a test

just a test

Item One | Item Two | Item Three

© Lorem Ipsum, Inc., 2020 Test 123456

  • Share this
  • Email this
  • Print this

Tool Tip

Use these tools to share this page with these popular sites
  • Google
  • Digg
  • Facebook
  • FriendFeed
  • Diigo
  • Yahoo
  • Fark
  • Twitter
  • Delicious
  • NewsVine
  • StumbleUpon
  • LinkedIn